Rehab and Mechanical Ventilation
REHAB-MV
Rehabilitation-based Approaches to Prevent Mechanical Ventilation-induced Breathing Dysfunction
1 other identifier
interventional
16
1 country
1
Brief Summary
The goal of this research study is to evaluate the effects of a single session of rehabilitation in healthy adults, before noninvasive mechanical ventilation (MV). MV can help support breathing function during sleep or illness. High levels of MV support have been reported to alter the function of the diaphragm muscle, the primary breathing muscle, in people with compromised health. However, rehabilitation may have some potential to improve diaphragm function in advance of using MV. This study will test different rehabilitation interventions, including (1) inspiratory strength training (IST), (2) transcutaneous spinal cord stimulation (TSCS), or sham TSCS. Before and after MV, participants will complete breathing strength tests and responses to phrenic nerve stimulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 17, 2026
CompletedFirst Posted
Study publicly available on registry
February 23, 2026
CompletedStudy Start
First participant enrolled
March 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
May 5, 2026
April 1, 2026
1 year
February 17, 2026
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Maximal inspiratory pressure
The most negative pressure generated during a maximal inspiratory effort.
T1: baseline strength, T2: 2 hours after MV, T3: 24 hours after MV
Phrenic CMAP Response
EMG response to supra maximal and bilateral phrenic stimulation
up to 24 hours
Secondary Outcomes (1)
Diaphragm thickness and excursion
up to 24 hours
Other Outcomes (1)
Two-minute step test (2M-ST)
Two hours and twenty-four hours post-MV.
Study Arms (3)
Sham Stimulation
SHAM COMPARATORTranscutaneous spinal cord stimulation at reduced intensity, lasting 1 minute at the beginning and end of a 20-minute session.
Spinal cord stimulation
ACTIVE COMPARATORTranscutaneous spinal cord stimulation at 2mA intensity, for 20 minutes.
Inspiratory strength training
EXPERIMENTAL5 sets of 5 breaths of high-intensity inspiratory strength training
Interventions
Transcutaneous spinal cord stimulation at 2mA intensity, for 20 minutes.
5 sets of 5 breaths of high-intensity inspiratory strength training
Transcutaneous spinal cord stimulation at reduced intensity, lasting 1 minute at the beginning and end of a 20-minute session.
Eligibility Criteria
You may qualify if:
- Non-smokers Sedentary or recreationally active Normal lung function No history of claustrophobia
You may not qualify if:
- Current smoking or vaping Obstructive lung disease Use of antibiotics or systemic corticosteroids to treat an acute condition History of sepsis or metastatic disease Post infectious conditions that affect breathing Diagnosed with a neurological or neuromuscular condition Any use of supplemental oxygen, continuous positive airway pressure (CPAP), or other positive pressure ventilation to treat sleep apnea Cardiac disease Orthopedic conditions that impair lung expansion Pregnancy Implanted metallic devices within 10 cm of the cervical spine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Florida
Gainesville, Florida, 32610, United States
Related Publications (7)
Ando R, Ohya T, Kusanagi K, Koizumi J, Ohnuma H, Katayama K, Suzuki Y. Effect of inspiratory resistive training on diaphragm shear modulus and accessory inspiratory muscle activation. Appl Physiol Nutr Metab. 2020 Aug;45(8):851-856. doi: 10.1139/apnm-2019-0906. Epub 2020 Feb 12.
PMID: 32049562BACKGROUNDLaghi F, Shaikh H, Littleton SW, Morales D, Jubran A, Tobin MJ. Inhibition of central activation of the diaphragm: a mechanism of weaning failure. J Appl Physiol (1985). 2020 Aug 1;129(2):366-376. doi: 10.1152/japplphysiol.00856.2019. Epub 2020 Jul 16.
PMID: 32673161BACKGROUNDNierat MC, Similowski T, Lamy JC. Does trans-spinal direct current stimulation alter phrenic motoneurons and respiratory neuromechanical outputs in humans? A double-blind, sham-controlled, randomized, crossover study. J Neurosci. 2014 Oct 22;34(43):14420-9. doi: 10.1523/JNEUROSCI.1288-14.2014.
PMID: 25339753BACKGROUNDLocher C, Raux M, Fiamma MN, Morelot-Panzini C, Zelter M, Derenne JP, Similowski T, Straus C. Inspiratory resistances facilitate the diaphragm response to transcranial stimulation in humans. BMC Physiol. 2006 Jul 29;6:7. doi: 10.1186/1472-6793-6-7.
PMID: 16875504BACKGROUNDHawkes EZ, Nowicky AV, McConnell AK. Diaphragm and intercostal surface EMG and muscle performance after acute inspiratory muscle loading. Respir Physiol Neurobiol. 2007 Mar 15;155(3):213-9. doi: 10.1016/j.resp.2006.06.002. Epub 2006 Jul 18.
PMID: 16846758BACKGROUNDFauroux B, Isabey D, Desmarais G, Brochard L, Harf A, Lofaso F. Nonchemical influence of inspiratory pressure support on inspiratory activity in humans. J Appl Physiol (1985). 1998 Dec;85(6):2169-75. doi: 10.1152/jappl.1998.85.6.2169.
PMID: 9843540BACKGROUNDBresciani G, Beaver T, Martin AD, van der Pijl R, Mankowski R, Leeuwenburgh C, Ottenheijm CAC, Martin T, Arnaoutakis G, Ahmed S, Mariani VM, Xue W, Smith BK, Ferreira LF. Intraoperative phrenic nerve stimulation to prevent diaphragm fiber weakness during thoracic surgery. PLoS One. 2025 Apr 1;20(4):e0320936. doi: 10.1371/journal.pone.0320936. eCollection 2025.
PMID: 40168300BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara K Smith, PhD
University of Florida
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 17, 2026
First Posted
February 23, 2026
Study Start
March 30, 2026
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- 9 months and ending 36 months following article publication.
- Access Criteria
- Investigators whose proposed use of the data has been approved by an independent review committee.
Participant data that underlie the results reported in this article after deidentification.